Moreno Menghini is a vitreoretinal specialist with research background in medical retina and imaging. He studied medicine at the University of Zurich, Switzerland, where he gained his MD for a thesis entitled Is pseudophakia a risk factor for neovascular age-related macular degeneration?. Moreno’s clinical training was undertaken at the University Hospital of Zurich, and the Cantonal Hospital of Lucerne, Switzerland.

In 2012 he was awarded the George and Rosalie Hearst Fellowship at the University of California, San Francisco, USA to undertake a medical retina and inherited retinal degenerations clinical fellowship under the mentorship of Professor Jacque Duncan. Thereafter he worked for a Swiss private eye clinic before having been granted the position of vitreoretinal fellow at Sir Charles Gairdner Hospital in Perth, Australia, where he trained under the supervision of Professor Ian Constable.

Through joint funding from Retina Suisse, the Swiss Foundation to Prevent and Fight Blindness, and the OPOS foundation, Moreno has currently been granted honorary clinical research and vitreoretinal fellow in the group of Professor MacLaren.

His clinical research focuses on RPGR X-linked retinitis pigmentosa, where he is co-investigator of the XOLARIS and XIRIUS trials. The current focus of the laboratory work is to investigate methods of gene silencing using the CRISPR pathway.